Search the Newsreel

AI Trading Plans Come Before Code in Waton’s AlphaSchema

Waton Financial announced research progress on AlphaSchema, a framework for structured, large-language-model-assisted discovery of quantitative trading signals. The company emphasizes prioritizing explicit, inspectable trading hypotheses before code generation, using semantic plans and historical Chinese equity data for backtesting. Waton clarifies that this is a …

What Atmos Energy (ATO)'s Earnings Beat, Guidance Reaffirmation and Leadership Moves Mean For Shareholders

Top Canadian Gold Stocks in August 2026: Agnico Eagle, Wheaton Precious Metals, Franco-Nevada and Kinross Lead the Pack

Dr. Reddy’s (RDY) to end Novartis India brand deal after Sept. 2026

Dr. Reddy's Laboratories Limited announced the termination of its distribution and promotion agreement with Novartis India Limited, effective September 30, 2026. This decision follows a change in the controlling shareholding of Novartis India. Dr. Reddy's will continue to commercialize the covered brands until the …

Mesa Labs Announces First Quarter Results

Mesa Laboratories, Inc. announced its first fiscal quarter results, showing a 1.0% increase in revenues and a 129% increase in operating income. The company reported positive core organic growth driven by its Calibration Solutions and Biopharmaceutical Development divisions, with a significant reduction in its …

Valiant Laboratories: मोठी घोषणा! ₹60 कोटींची गुंतवणूक आणि ऑफिस स्थलांतर

Valiant Laboratories Q1 FY27: सब्सिडियरी के दम पर मुनाफे में भारी उछाल, ₹21.10 करोड़ का नेट प्रॉफिट!

Valiant Laboratories: முதல் காலாண்டில் **₹21.10 கோடி** லாபம், புதிய உச்சத்தை தொட்டது!

Waton Financial Highlights AlphaSchema Research Progress in Structured AI-Assisted Trading Signal Discovery

Waton Financial Limited has announced significant progress with AlphaSchema, a research framework designed for AI-assisted discovery of quantitative trading signals. This initiative, detailed in an arXiv preprint and a public source-code repository, emphasizes transforming model-generated ideas into explicit, testable hypotheses before implementation. The research …

Infleqtion Selected by Eaton to Explore Quantum Computing for Power Grid Resilience

Infleqtion has been chosen by Eaton to provide quantum computing technology for a research program funded by the Air Force Research Laboratory. This collaboration aims to enhance the resilience of the U.S. electrical grid by evaluating how quantum algorithms and neutral-atom quantum hardware can …

Abbott Continues to Oppose Spinal Cord Stimulator Lawsuit MDL, Despite Mounting Claims

Abbott Laboratories is opposing the consolidation of spinal cord stimulator lawsuits into a multidistrict litigation (MDL), despite a growing number of claims alleging dangerous defects in its devices. While a similar MDL has already been established for Boston Scientific, Abbott argues that its cases …

International Markets and Charles River (CRL): A Deep Dive for Investors

Have you looked into how Charles River Laboratories (CRL) performed internationally during the quarter ending June 2026? Considering the widespread global presence of this medical research equipment and services provider, examining the trends in international revenues is essential for assessing its financial resilience and …

Don't Overlook Bio-Rad (BIO) International Revenue Trends While Assessing the Stock

Have you assessed how the international operations of Bio-Rad Laboratories (BIO) performed in the quarter ended June 2026? For this maker of instruments used in biomedical research, possessing an expansive global footprint, parsing the trends of international revenues could be critical to gauge its …

Atossa Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

Atossa Therapeutics Inc has reported its earnings summary for the quarter that ended on June 30. The article, sourced from Reuters, provides a brief overview of the company's financial results. Access to the full report is available through a subscription to TradingView.

How Investors Are Reacting To Stevanato Group (STVN) Trimmed Guidance And New GLP-1 Pen Approvals

Stevanato Group S.p.A. recently reported past second-quarter 2026 results showing sales of €302 million with lower net income, slightly trimmed its full-year revenue guidance to €1.26–€1.28 billion, and outlined expected diluted EPS of €0.53–€0.55. At the same time, the company's Alina pen injector platform …

KTOS Looks 89.4% Overvalued on GF Value™

Kratos Defense & Security Solutions Inc (NASDAQ: KTOS) appears significantly overvalued according to GuruFocus's GF Value™ metric, trading 89.4% above its intrinsic value estimate. Despite its role in advancing missile defense technologies and strong growth profile, the company remains unprofitable and cash-flow negative, leading …

Charles River Laboratories , Inc. Stock 12‑Month Price Target Raised to $291.46, Implies 9% Upside

Analysts have raised the 12-month average price target for Charles River Laboratories International, Inc. (CRL) stock from $285.54 to $291.46, implying a 9% potential upside based on its August 7th closing price. The consensus rating from 19 analysts remains "Buy," with a majority recommending …

Infleqtion Selected by Eaton to Support Research Advancing Quantum Computing for U.S. Grid Resilience

Multi-year, multi-million-dollar program focused on leveraging quantum computing to enhance resilience of U.S. electrical grid and reduce economic impact of power outages. LOUISVILLE, Colo., August 10, 2026--(BUSINESS WIRE)--Infleqtion, a global leader in quantum computing and quantum sensing powered by neutral-atom technology, announced that Eaton, …

TD Cowen Adjusts PT on Charles River Laboratories International to $300 From $235, Maintains Buy Rating

TD Cowen has increased its price target for Charles River Laboratories International (CRL) to $300 from $235, while reiterating a Buy rating on the stock. This adjustment comes amidst other analyst updates for the company, indicating positive sentiment following recent financial announcements. The article …

Atmos Energy Names Natural Gas Industry Adviser James Jeffries to Board

Atmos Energy (NYSE: ATO) has appointed James H. Jeffries IV to its board of directors, effective September 1, 2026. Jeffries brings over 30 years of experience advising natural gas utilities and was previously a partner at McGuireWoods LLP. His appointment is expected to strengthen …

Atmos Energy Names Jeff Martinez to Lead Utility Operations as John McDill Retires

Atmos Energy has appointed Jeff D. Martinez as senior vice president of utility operations, effective October 1, 2026, succeeding John S. McDill who plans to retire in early 2027. Martinez, a long-time company executive, will join the Management Committee and report to President and …

Kratos Target Vehicles Help Japan’s Radar Track Simulated Targets

Kratos Defense & Security Solutions (Nasdaq: KTOS) announced its target systems supported the U.S. Missile Defense Agency and Japan Maritime Self-Defense Force during the Japan Flight Test Experiment-01 (JFTX-01) in March 2026. This mission was crucial for testing Japan’s Aegis System Equipped Vessel Shipset …

Kratos Defense & Security Solutions, Inc. Provides Target Systems for Missile Defense Agency and Japan Maritime Self-Defense Force Joint Flight Test Experiment-01 Mission

Kratos Defense & Security Solutions, Inc. provided target vehicles for the Missile Defense Agency and Japan Maritime Self-Defense Force's Joint Flight Test Experiment-01. These target systems enabled the SPY-7 radar to successfully detect, track, and deliver simulated engagement solutions during the March 17 and …

Form 8K Atmos Energy Corp For: 10 August By Investing.com

This article reports on the filing of Form 8K by Atmos Energy Corp on August 10, 2026. Form 8K is a crucial document that public companies must file with the SEC to announce major events that shareholders should know about. The article includes the …

Stevanato Group (STVN) Stock Looks Cheap On Cash Flow But Pricey On Earnings

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Stevanato Group stock has declined 34.6% over the past three years, and current checks send mixed valuation signals, with an intrinsic value estimate …

Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma

Labcorp (NYSE: LH) has announced that the FDA approved its PGDx elio® tissue complete CDx as a companion diagnostic. This diagnostic tool helps identify patients with advanced melanoma who have specific BRAF variants, making them eligible for targeted BRAF and BRAF/MEK inhibitor therapies. This …

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. : TD COWEN RAISES TARGET PRICE TO $300 FROM $235

TD Cowen has increased its target price for Charles River Laboratories International, Inc. (CRL.N) to $300 from $235. This update reflects a change in the analyst's outlook for the company's stock. The article is a brief news alert from Reuters regarding this financial analyst …

Top Industrial Stocks to Watch: What’s Shaping Eaton’s (NYSE:ETN) Market Outlook?

This article from Kalkine Media discusses the market outlook for Eaton (NYSE:ETN), focusing on factors shaping its performance within the industrial stocks sector. It highlights the company's relevance to grid expansion themes and how operating conditions, capital allocation, demand, competition, regulation, and execution influence …

Stevanato Group S.p.A. (STVN): Investor Outlook Reveals 23.83% Potential Upside

Stevanato Group S.p.A. (STVN), a healthcare company specializing in medical instruments, is currently trading at $20.27 with a market capitalization of $5.53 billion. Analysts predict a potential upside of 23.83%, with an average target price of $25.10. Despite negative free cash flow, the company …

Horace Mann Educators Corporation (HMN) Stock Price, News, Quote & History

This page provides comprehensive financial data for Horace Mann Educators Corporation (HMN), including its current stock price, recent performance metrics, and key financial statistics. It details the company's operational segments in Property & Casualty, Life & Retirement, and Supplemental & Group Benefits insurance. The …

Atmos Energy’s Utility Operations Chief to Retire in Early 2027

Atmos Energy Corporation announced that John S. McDill, Senior Vice President, Utility Operations, will retire in early 2027 after a long career with the company. Jeff D. Martinez has been appointed to succeed McDill as Senior Vice President, Utility Operations, effective October 1, 2026. …

Atmos Energy Corporation Names James H. Jeffries IV to Board of Directors

Atmos Energy Corporation announced the election of James H. Jeffries IV to its board of directors, effective September 1, 2026. Mr. Jeffries, a retiring partner from McGuire Woods LLP, brings over three decades of experience advising companies in the natural gas utility sector. The …

Fluent Financial LLC Makes New $1.73 Million Investment in Abbott Laboratories $ABT

Atmos Energy Corporation Announces Retirement of John S. McDill and Appointment of Jeff D. Martinez to Senior Vice President, Utility Operations

DALLAS, August 10, 2026--(BUSINESS WIRE)--Atmos Energy Corporation (NYSE: ATO) announced today that John S. McDill, currently Senior Vice President, Utility Operations, will retire in early 2027 after a distinguished career with the Company. He will serve in his current role and on the company's …

Vertrix Wealth Management LLC Invests $2.67 Million in Abbott Laboratories $ABT

Vertrix Wealth Management LLC initiated a new position in Abbott Laboratories (NYSE:ABT) during the second quarter, purchasing 29,377 shares valued at approximately $2.67 million. Institutional investors collectively own about 75.18% of the company. Abbott Laboratories reported strong quarterly earnings and revenue, beating estimates, and …

Renaissance Technologies LLC Has $2.79 Million Holdings in Mesa Laboratories, Inc. $MLAB

Renaissance Technologies LLC significantly increased its stake in Mesa Laboratories (MLAB) by 802.9% in Q1, now holding 31,600 shares valued at $2.79 million. Despite institutional ownership reaching 90.6%, the company missed Q1 analyst estimates for revenue and EPS. Analysts maintain a "Reduce" rating for …